Best practices on critical reagent characterization, qualification, and life cycle management for HCP immunoassays
- 9 July 2021
- journal article
- review article
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 118 (10) , 3633-3639
Abstract
The performance of immunoassays for the detection and quantification of host‐cell proteins (HCPs) in biopharmaceuticals depends on the quality of the critical assay reagents. Not only their preparation, but also a stringent life‐cycle management, including reagent qualification, requalification, and replacement, plays a crucial role in ensuring consistent and reliable results. To provide a cross‐industry perspective on HCP reagent management, we conducted a survey on common practices among several pharmaceutical and biotech companies. Based on its outcome, as well as informed by a corresponding roundtable session (“Managing critical reagents over time”) at the BioPharmaceutical Emerging Best Practices Association HCP conference in 2019, this study presents specific recommendations and proven concepts to support immunoassay reagent management for monitoring HCPs.Keywords
This publication has 11 references indexed in Scilit:
- A novel approach to evaluate ELISA antibody coverage of host cell proteins—combining ELISA‐based immunocapture and mass spectrometryBiotechnology Progress, 2020
- Evaluation of Peptide Fractionation and Native Digestion as Two Novel Sample Preparation Workflows to Improve HCP Characterization by LC–MS/MSAnalytical Chemistry, 2019
- Host Cell Protein Profiling in Biopharmaceutical HarvestsAnalytical Chemistry, 2018
- Comparison of purification strategies for antibodies used in a broad spectrum host cell protein immunoassayBiotechnology and Bioengineering, 2017
- ELISA reagent coverage evaluation by affinity purification tandem mass spectrometrymAbs, 2017
- A Novel Sample Preparation for Shotgun Proteomics Characterization of HCPs in AntibodiesAnalytical Chemistry, 2017
- A modular and adaptive mass spectrometry-based platform for support of bioprocess development toward optimal host cell protein clearancemAbs, 2017
- Host cell proteins in biotechnology‐derived products: A risk assessment frameworkBiotechnology and Bioengineering, 2015
- More similar than different: Host cell protein production using three null CHO cell linesBiotechnology and Bioengineering, 2015
- Host cell proteins in biologics development: Identification, quantitation and risk assessmentBiotechnology and Bioengineering, 2009